FIRST THERAPEUTIC INHIBITOR OF 5-LIPOXIGENASE Trademark
Serial Number: 74522456
FIRST THERAPEUTIC INHIBITOR OF 5-LIPOXIGENASE is a trademark filed by
ABBOTT LABORATORIES
on May 5, 1994. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
FRANCES M JAGLA
ONE ABBOTT PARK RD
ABBOTT PARK
IL 60064-3500
UNITED STATES
Trademark Details
Filing Date
May 5, 1994
Registration Date
Not Registered
Published for Opposition
November 28, 1995
Filing History
ABANDONMENT - NO USE STATEMENT FILED
Aug 21, 1997 ABN6
ABANDONMENT - NO USE STATEMENT FILED
Aug 21, 1997 ABN6
SOU EXTENSION 2 GRANTED
Mar 27, 1997 EX2G
SOU EXTENSION 2 GRANTED
Mar 27, 1997 EX2G
SOU EXTENSION 2 FILED
Feb 19, 1997 EXT2
SOU EXTENSION 2 FILED
Feb 19, 1997 EXT2
SOU EXTENSION 1 GRANTED
Sep 19, 1996 EX1G
SOU EXTENSION 1 GRANTED
Sep 19, 1996 EX1G
SOU EXTENSION 1 FILED
Jul 19, 1996 EXT1
SOU EXTENSION 1 FILED
Jul 19, 1996 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 20, 1996 NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 20, 1996 NOAM
PUBLISHED FOR OPPOSITION
Nov 28, 1995 PUBO
PUBLISHED FOR OPPOSITION
Nov 28, 1995 PUBO
NOTICE OF PUBLICATION
Oct 27, 1995 NPUB
NOTICE OF PUBLICATION
Oct 27, 1995 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 22, 1995 CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 22, 1995 CNSA
EXAMINER'S AMENDMENT MAILED
Sep 14, 1995 CNEA
EXAMINER'S AMENDMENT MAILED
Sep 14, 1995 CNEA
ASSIGNED TO EXAMINER
Sep 5, 1995 DOCK
ASSIGNED TO EXAMINER
Sep 5, 1995 DOCK
ASSIGNED TO EXAMINER
Sep 1, 1995 DOCK
ASSIGNED TO EXAMINER
Sep 1, 1995 DOCK
ASSIGNED TO EXAMINER
Sep 1, 1995 DOCK
ASSIGNED TO EXAMINER
Sep 1, 1995 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 1995 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 1995 CRFA
NON-FINAL ACTION MAILED
Feb 7, 1995 CNRT
NON-FINAL ACTION MAILED
Feb 7, 1995 CNRT
ASSIGNED TO EXAMINER
Sep 19, 1994 DOCK
ASSIGNED TO EXAMINER
Sep 19, 1994 DOCK
